Retatrutide Shows Cardiovascular Biomarker Benefits in Obesity Study | Retatrutide News

Retatrutide may improve cardiovascular risk biomarkers in adults with obesity, with or without type 2 diabetes. This suggests potential benefits beyond ...
Clinical Trials · October 17, 2026